Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited

NCT03320811 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT03320811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03320811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited
Lead sponsor
CHU de Reims
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
January 1, 2016
Enrollment
2,026 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease